Skip to content

A prospective, randomized, controlled trial for the efficacy of repetitive transcranial magnetic stimulation in spinocerebellar ataxia type 3

A prospective, randomized, controlled trial for the efficacy of repetitive transcranial magnetic stimulation in spinocerebellar ataxia type 3

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020133
Enrollment
Unknown
Registered
2018-12-15
Start date
2018-12-17
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinocerebellar ataxia type 3

Interventions

1:Sham stimulate

Sponsors

First Affiliated Hospital, Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with detectable clinical signs and confirmed genetic diagnosis with SCA3; 2. SCA3 patients aged 20 - 80 years; 3. Patients or their family members have informed consent to the study and signed relevant documents.

Exclusion criteria

Exclusion criteria: 1. Patients who have concomitant epilepsy; 2. History of seizure or heat convulsion; 3. Patients on neuroleptics; 4. Patients with dementia (MMSE<25) or any unstable medical disorder; 5. History or current unstable hypertension; 6. History of head injury or neurosurgical interventions; 7. History of any metal in the head (outside the mouth); 8. Known history of any metallic particles in the eye, implanted cardiac pacemaker, implanted neurostimulators, surgical clips (above the shoulder line) or any medical pumps; 9. History of frequent or severe headaches; 10. History of migraine; 11. History of hearing loss; 12. History of cochlear implants; 13. History of drug abuse or alcoholism; 14. Pregnancy or not using a reliable method of birth control; 15. Participation in current clinical study.

Design outcomes

Primary

MeasureTime frame
International Cooperative Ataxia Rating Scale (ICARS);

Countries

China

Contacts

Public ContactShi-Rui Gan

First Affiliated Hospital, Fujian Medical University

ganshirui@fjmu.edu.cn+86 13850172725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026